Fig. 2From: Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNAPhantom drawing of clinical applications of liquid biopsy in HCC patients. Monitoring the response and relapse of HCC patients using liquid biopsy, the levels of ctDNA and CTCs correlate well with HCC progression as well as various therapies, including surgical resection, TACE, radiofrequency ablation (RFA) and targeted molecular therapyBack to article page